CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 143 enrolled
Drug / intervention
DHOPE-COR-NMPprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06804746
NCT06804746N/ACompleted

Safe Transplantation of Extended Criteria Donor Livers: Two-center Experience With Resuscitation and Viability Assessment of 206 Livers Using Sequential Hypo- and Normothermic Machine Perfusion

Erasmus Medical Center·observational·Posted Feb 3, 2025·Updated Jan 27, 2026

In Brief

An observational study evaluating DHOPE-COR-NMP for Liver Transplantation. Completed, enrolled 143 participants across 2 sites.

Detailed Summary

The goal of this observational study is to learn whether extended criteria donor livers can be safely transplanted after sequential hypo- and normothermic machine perfusion in recipients requiring a liver transplant for end-stage liver disease, including a long-term follow-up. The main questions it aims to answer are: * Death censored graft-survival * Overall patient survival * Frequency of frequent post-transplant complications (e.g. non-anastomotic biliary strictures)

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesNetherlands

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 3, 2025
Enrollment StartMar 1, 2019
Primary CompletionMay 1, 2025
Study CompletionOct 31, 2025
TodayJul 2, 2026
Enrollment to primary: 6.2 yearsPosted 1.4 years ago

Interventions

DHOPE-COR-NMPprocedure

Resuscitation and viability assessment through the previously published protocol of sequential hypo- and normothermic liver machine perfusion with controlled oxygenated rewarming (DHOPE-COR-NMP) based on a blood-based perfusate.